The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond ...

The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...

Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are ...

Ballerup, Denmark Saturday, July 26, 2025, 15:00 Hrs [IST] ...

The first therapy specifically indicated for chronic hand eczema (CHE) has passed muster at the FDA.

Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (del | Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no ...

LEO Pharma Inc. announced today that the Food and Drug Administration (FDA) has approved ANZUPGO® (delgocitinib) cream for ...

LEO Pharma’s Anzupgo (delgocitinib) cream has been approved by the US Food and Drug Administration (FDA) to treat adults with ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Becoming the first approved treatment for chronic hand eczema in the U.S., Leo Pharma A/S’s Anzupgo (delgocitinib) received ...

Chronic hand eczema (CHE) is a persistent, inflammatory skin disorder characterised by redness, itching, and the formation of vesicles on the hands that can result in pain and a significant ...